Financial Gravity Companies, Inc. Takeda Pharmaceutical CO LTD Transaction History
Financial Gravity Companies, Inc.
- $438 Billion
- Q4 2024
A detailed history of Financial Gravity Companies, Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Financial Gravity Companies, Inc. holds 148 shares of TAK stock, worth $2,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
148Holding current value
$2,080% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TAK
# of Institutions
338Shares Held
68.6MCall Options Held
1.72MPut Options Held
178K-
Capital Research Global Investors Los Angeles, CA13.2MShares$185 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.6MShares$78.7 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$65.1 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$59.3 Million0.05% of portfolio
-
First Trust Advisors LP Wheaton, IL3.24MShares$45.6 Million0.04% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.7B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...